Eagle Wealth Strategies’s Boston Scientific BSX Stock Holding History

Eagle Wealth Strategies’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$338K	Sell	7,913 -535	-6%	-$29.1K	0.13%	76
2026 Q1	$530K	Buy	8,448 +122	+1%	+$9.76K	0.23%	45
2025 Q4	$794K	Buy	8,326 +381	+5%	+$37.4K	0.37%	31
2025 Q3	$776K	Buy	7,945 +75	+1%	+$7.77K	0.39%	26
2025 Q2	$845K	Buy	7,870 +157	+2%	+$15.9K	0.47%	24
2025 Q1	$778K	Sell	7,713 -980	-11%	-$98.7K	0.48%	21
2024 Q4	$776K	Buy	8,693 +31	+0.4%	+$2.73K	0.56%	20
2024 Q3	$726K	Sell	8,662 -572	-6%	-$45.1K	0.53%	22
2024 Q2	$711K	Sell	9,234 -8	-0.1%	-$586	0.58%	21
2024 Q1	$629K	Sell	9,242 -115	-1%	-$7.39K	0.51%	26
2023 Q4	$541K	Buy	+9,357	New	+$499K	0.33%	32

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Eagle Wealth Strategies's BSX Position: Q2 2026 in Review

Eagle Wealth Strategies reduced its Boston Scientific (BSX) stake by 6.3% in Q2 2026, selling an estimated $29.1K and leaving 7,913 shares worth $338K. The position accounts for 0.13% of the portfolio, ranked #76.

Eagle Wealth Strategies first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $845K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Eagle Wealth Strategies held 7,913 shares of Boston Scientific worth $338K as of Q2 2026.
Eagle Wealth Strategies sold 535 Boston Scientific shares in Q2 2026, an estimated $29.1K.
Boston Scientific made up 0.13% of Eagle Wealth Strategies's portfolio in Q2 2026, its #76 holding.
Eagle Wealth Strategies first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
Eagle Wealth Strategies's Boston Scientific position peaked at $845K in Q2 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Eagle Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.